Saving changes...

Done

Error

Metronomic Chemotheraphy in Clincial Practice: Time to Rethink the Targets and Redefine the Strategies of Anti-Cancer Theraphy

Metronomic Chemotheraphy in Clincial Practice: Time to Rethink the Targets and Redefine the Strategies of Anti-Cancer Theraphy

Metronomic Chemotheraphy in Clincial Practice: Time to Rethink the Targets and Redefine the Strategies of Anti-Cancer Theraphy

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 12.50 $ 12.50 $ 12.50
Normal Price: FREE $12.50

Review:

Launch date: 17 Apr 2015

Expiry Date:

Last updated: 24 Oct 2017

Reference: 151058

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This talk will review the use of tyrosine kinase inhibitors and metronomic chemotherapy in human and veterinary oncology. We will then explore the scientific data that supports their use as an adjunct to tumor immunotherapy and potential application of this treatment strategy to our veterinary cancer patients.

Objectives

Objectives
This talk will review the use of tyrosine kinase inhibitors and metronomic chemotherapy in human and veterinary oncology. We will then explore the scientific data that supports their use as an adjunct to tumor immunotherapy and potential application of this treatment strategy to our veterinary cancer patients.
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

Dr. Barbara Biller
Credentials: DVM, MS, PhD, Diplomate ACVIM (Oncology). Dr. Biller obtained her DVM degree from the University of Wisconsin-Madison in 1993. She completed a rotating internship in small animal medicine and surgery at Colorado State University in 1994 and then a residency in medical oncology at the University of Illinois with board certification in oncology in 1997. After several years in private practice as an oncologist in the Denver area, Dr. Biller pursued and completed a PhD in Immunology at Colorado State University in 2007. She is currently an Associate Professor of Oncology at Colorado State University. Her research interests include the immunomodulatory effects of chemotherapy and application of immunotherapies to veterinary cancer patients.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.50 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error